NO20081206L - Isoquinolines derivatives as IGF -1R inhibitors - Google Patents
Isoquinolines derivatives as IGF -1R inhibitorsInfo
- Publication number
- NO20081206L NO20081206L NO20081206A NO20081206A NO20081206L NO 20081206 L NO20081206 L NO 20081206L NO 20081206 A NO20081206 A NO 20081206A NO 20081206 A NO20081206 A NO 20081206A NO 20081206 L NO20081206 L NO 20081206L
- Authority
- NO
- Norway
- Prior art keywords
- igf
- inhibitors
- isoquinolines
- derivatives
- isoquinolines derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
- C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/62—Isoquinoline or hydrogenated isoquinoline ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71517005P | 2005-09-09 | 2005-09-09 | |
IB2005002667 | 2005-09-09 | ||
PCT/IB2006/002474 WO2007029107A1 (fr) | 2005-09-09 | 2006-09-08 | Derives d'isoquinolines utilises en tant qu'inhibiteurs d'igf-1r |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20081206L true NO20081206L (no) | 2008-05-29 |
Family
ID=37460368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20081206A NO20081206L (no) | 2005-09-09 | 2008-03-07 | Isoquinolines derivatives as IGF -1R inhibitors |
Country Status (10)
Country | Link |
---|---|
US (1) | US20090099133A1 (fr) |
EP (1) | EP1940796A1 (fr) |
JP (1) | JP2009507820A (fr) |
KR (1) | KR20080065591A (fr) |
AU (1) | AU2006288847A1 (fr) |
BR (1) | BRPI0616731A2 (fr) |
CA (1) | CA2621820A1 (fr) |
EA (1) | EA200800786A1 (fr) |
NO (1) | NO20081206L (fr) |
WO (1) | WO2007029107A1 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011112666A1 (fr) | 2010-03-09 | 2011-09-15 | OSI Pharmaceuticals, LLC | Thérapie anticancéreuse combinatoire |
EP2671082B1 (fr) | 2011-02-02 | 2020-01-15 | Amgen Inc. | Méthodes et compositions associées à l'inhibition d'igf-1r |
US20140046059A1 (en) * | 2011-04-21 | 2014-02-13 | Piramal Enterprises Limited | Process for the preparation of morpholino sulfonyl indole derivatives |
EP2776042B1 (fr) | 2011-11-11 | 2019-03-20 | Duke University | Polythérapie médicamenteuse pour le traitement de tumeurs solides |
US8980259B2 (en) | 2012-07-20 | 2015-03-17 | Novartis Ag | Combination therapy |
JP6644713B2 (ja) | 2014-02-24 | 2020-02-12 | ヴェンタナ メディカル システムズ, インク. | キノンメチドアナログシグナル増幅 |
US9758539B2 (en) * | 2015-05-18 | 2017-09-12 | Tolero Pharmaceuticals, Inc. | Alvocidib prodrugs having increased bioavailability |
WO2017129763A1 (fr) | 2016-01-28 | 2017-08-03 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Méthodes et compositions pharmaceutiques pour le traitement du cancer de l'estomac à cellules en bague à chaton |
US11279694B2 (en) | 2016-11-18 | 2022-03-22 | Sumitomo Dainippon Pharma Oncology, Inc. | Alvocidib prodrugs and their use as protein kinase inhibitors |
JP7196160B2 (ja) | 2017-09-12 | 2022-12-26 | スミトモ ファーマ オンコロジー, インコーポレイテッド | Mcl-1阻害剤アルボシジブを用いた、bcl-2阻害剤に対して非感受性である癌の治療レジメン |
MX2021006544A (es) | 2018-12-04 | 2021-07-07 | Sumitomo Pharma Oncology Inc | Inhibidores de cinasa dependiente de ciclina 9 (cdk9) y polimorfos de los mismos para uso como agentes para el tratamiento de cancer. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000035455A1 (fr) * | 1998-12-15 | 2000-06-22 | Telik, Inc. | Urees heteroaryle-aryle utilisees comme antagonistes du recepteur igf-1 |
EP1113007A1 (fr) * | 1999-12-24 | 2001-07-04 | Pfizer Inc. | Composés de tétrahydroisoquinoline comme agonistes/antagonistes d'oestrogène |
SE0203746D0 (sv) * | 2002-12-18 | 2002-12-18 | Karolinska Innovations Ab | New compounds |
ES2299825T3 (es) * | 2004-03-12 | 2008-06-01 | Analytecon S.A. | Derivados de tetrahidroisoquinoleino y de tetrahidrobenzazepina utilizados como inhibidores de igf-1r. |
-
2006
- 2006-09-08 EA EA200800786A patent/EA200800786A1/ru unknown
- 2006-09-08 KR KR1020087006725A patent/KR20080065591A/ko not_active Application Discontinuation
- 2006-09-08 EP EP06795449A patent/EP1940796A1/fr not_active Withdrawn
- 2006-09-08 AU AU2006288847A patent/AU2006288847A1/en not_active Abandoned
- 2006-09-08 WO PCT/IB2006/002474 patent/WO2007029107A1/fr active Application Filing
- 2006-09-08 CA CA002621820A patent/CA2621820A1/fr not_active Abandoned
- 2006-09-08 BR BRPI0616731A patent/BRPI0616731A2/pt not_active IP Right Cessation
- 2006-09-08 JP JP2008529711A patent/JP2009507820A/ja not_active Withdrawn
- 2006-09-08 US US11/991,531 patent/US20090099133A1/en not_active Abandoned
-
2008
- 2008-03-07 NO NO20081206A patent/NO20081206L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2006288847A1 (en) | 2007-03-15 |
KR20080065591A (ko) | 2008-07-14 |
JP2009507820A (ja) | 2009-02-26 |
EA200800786A1 (ru) | 2008-08-29 |
CA2621820A1 (fr) | 2007-03-15 |
EP1940796A1 (fr) | 2008-07-09 |
BRPI0616731A2 (pt) | 2016-08-23 |
WO2007029107A1 (fr) | 2007-03-15 |
US20090099133A1 (en) | 2009-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20081206L (no) | Isoquinolines derivatives as IGF -1R inhibitors | |
EA200801608A1 (ru) | Производные бензимидазолонкарбоновой кислоты | |
ATE429427T1 (de) | Pyrimidinderivate als orexin-rezeptorantagonisten | |
TN2010000052A1 (fr) | Derives de pyrazole et leur utilisation comme inhibiteurs de raf | |
UA107175C2 (uk) | Спосіб і сполука, призначені для одержання інгібіторів контранспортера натрій-глюкози 2 типу, варіанти | |
MX2009003834A (es) | Derivados de pirrolidina como inhibidores de iap. | |
EA201000642A1 (ru) | 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы | |
BRPI1009333B8 (pt) | compostos inibidores de beta-secretase, seus usos, bem como composição farmacêutica | |
TW200626610A (en) | Analogs of 17-hydroxywortmannin as PI3K inhibitors | |
NO20072963L (no) | 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere | |
EA201791254A1 (ru) | Кристаллические сольваты и комплексы производных (1s)-1,5-ангидро-1-c-(3-((фенил)метил)фенил)-d-глюцитола с аминокислотами в качестве ингибиторов sglt2 для лечения диабета | |
NO20071242L (no) | Triazolpyridinylsulfanylderivater som P38-MAP-kinaseinhibitorer | |
EA200970156A1 (ru) | Пиридизиноновые производные | |
EA200700365A1 (ru) | Производные индол-2-карбоксамидина как антагонисты nmda рецептора | |
BRPI0814065B8 (pt) | derivados de alcoóis de 1-fenil-2-piridinil alquila como inibidores da fosfodiesterase | |
EA201001683A1 (ru) | Производные фенил- или пиридинилзамещенных индазолов | |
EA200701328A1 (ru) | Замещенные триазольные производные в качестве антагонистов окситоцина | |
NO20081207L (no) | Isoquinolines as IGF-1R inhibitors | |
NO20081001L (no) | Derivater av karboksamid som antagonister for muskarinisk reseptor | |
EA200801145A1 (ru) | Спироциклические производные хиназолина в качестве ингибиторов pde7 | |
MA32296B1 (fr) | Derives de piperidine 3,4-substitues comme inhibiteurs de la renine | |
BRPI0509731A (pt) | pirazol[4,3-d]pirimidinas | |
NO20081621L (no) | Tetrahydrokinoliner, syntese og intermediater | |
EA200801366A1 (ru) | Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина | |
NO20080468L (no) | Diazepinokinoliner, synteser av disse samt intermediater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |